| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品(元) | 239,318,417.23 | 383,557,256.20 | 217,165,064.44 | 301,670,664.11 | 105,390,966.51 |
| 医药中间体(元) | 1,332,442.79 | 2,805,075.22 | 2,732,508.85 | 634,393.38 | 9,070.80 |
| 资产租赁(元) | 45,871.56 | 76,452.60 | 30,581.04 | - | - |
| 营业成本(元) | |||||
| 药品(元) | 16,281,615.31 | 28,209,030.63 | - | 25,707,224.58 | - |
| 医药中间体(元) | 1,202,812.37 | 983,809.82 | - | 453,797.68 | - |
| 资产租赁(元) | 11,553.30 | 19,255.50 | - | - | - |
| 毛利(元) | |||||
| 药品(元) | 223,036,801.92 | 355,348,225.57 | - | 275,963,439.53 | - |
| 医药中间体(元) | 129,630.42 | 1,821,265.40 | - | 180,595.70 | - |
| 资产租赁(元) | 34,318.26 | 57,197.10 | - | - | - |
| 毛利率(%) | |||||
| 药品(%) | 93.20 | 92.65 | - | 91.48 | - |
| 医药中间体(%) | 9.73 | 64.93 | - | 28.47 | - |
| 资产租赁(%) | 74.81 | 74.81 | - | - | - |
| 收入构成(%) | |||||
| 药品(%) | 99.43 | 99.25 | 98.74 | 99.79 | 99.99 |
| 医药中间体(%) | 0.55 | 0.73 | 1.24 | 0.21 | 0.01 |
| 资产租赁(%) | 0.02 | 0.02 | 0.01 | - | - |
| 毛利构成(%) | |||||
| 药品(%) | 99.93 | 99.47 | - | 99.93 | - |
| 医药中间体(%) | 0.06 | 0.51 | - | 0.07 | - |
| 资产租赁(%) | 0.02 | 0.02 | - | - | - |